Guangzhou Improve Med Instrument Cash Flow Conversion Efficiency
Guangzhou Improve Med Instrument cash flow conversion efficiency. Based on the latest financial reports, Guangzhou Improve Med Instrument (300030) has a cash flow conversion efficiency ratio of 0.106x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥70.22 Million ≈ $10.27 Million USD) by net assets (CN¥664.29 Million ≈ $97.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Guangzhou Improve Med Instrument (2006–2025)
Cash flow conversion efficiency of Guangzhou Improve Med Instrument from 2006 to 2025. This chart illustrates how Guangzhou Improve Med Instrument's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 300030 live share price for real-time trading data and today's change.
Guangzhou Improve Med Instrument Cash Flow Conversion Ratio Explained
Guangzhou Improve Med Instrument cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Guangzhou Improve Med Instrument Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guangzhou Improve Med Instrument ranked by their cash flow conversion efficiency. Also see how much is Guangzhou Improve Med Instrument worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sangam (India) Limited
NSE:SANGAMIND
|
0.009x |
|
Zhejiang Dayang Biotech Group Co
SHE:003017
|
0.001x |
|
Shifeng Cultural Development Co Ltd
SHE:002862
|
0.031x |
|
Jiangsu Tongda Power Technology Co Ltd
SHE:002576
|
0.007x |
|
Teqnion AB
ST:TEQ
|
0.039x |
|
Ve Wong Corp
TW:1203
|
0.018x |
|
Shui On Land Limited
F:OL5
|
0.011x |
|
Hunan Creator Information Technologies Co Ltd Class A
SHE:300730
|
-0.007x |
Annual Cash Flow Conversion Efficiency for Guangzhou Improve Med Instrument (2006–2025)
The table below shows the annual cash flow conversion efficiency of Guangzhou Improve Med Instrument from 2006 to 2025. Review Guangzhou Improve Med Instrument free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥655.10 Million ≈ $95.86 Million |
CN¥109.90 Million ≈ $16.08 Million |
0.168x | +31.99% |
| 2024-12-31 | CN¥643.86 Million ≈ $94.22 Million |
CN¥81.84 Million ≈ $11.98 Million |
0.127x | +21.26% |
| 2023-12-31 | CN¥762.33 Million ≈ $111.55 Million |
CN¥79.90 Million ≈ $11.69 Million |
0.105x | +102.49% |
| 2022-12-31 | CN¥820.61 Million ≈ $120.08 Million |
CN¥42.48 Million ≈ $6.22 Million |
0.052x | -68.94% |
| 2021-12-31 | CN¥1.03 Billion ≈ $150.78 Million |
CN¥171.74 Million ≈ $25.13 Million |
0.167x | +18.31% |
| 2020-12-31 | CN¥1.00 Billion ≈ $146.74 Million |
CN¥141.27 Million ≈ $20.67 Million |
0.141x | +140.21% |
| 2019-12-31 | CN¥838.26 Million ≈ $122.66 Million |
CN¥49.16 Million ≈ $7.19 Million |
0.059x | -14.65% |
| 2018-12-31 | CN¥815.47 Million ≈ $119.33 Million |
CN¥56.04 Million ≈ $8.20 Million |
0.069x | -53.43% |
| 2017-12-31 | CN¥963.72 Million ≈ $141.02 Million |
CN¥142.19 Million ≈ $20.81 Million |
0.148x | +507.22% |
| 2016-12-31 | CN¥954.18 Million ≈ $139.63 Million |
CN¥23.19 Million ≈ $3.39 Million |
0.024x | +381.92% |
| 2015-12-31 | CN¥930.46 Million ≈ $136.16 Million |
CN¥-8.02 Million ≈ $-1.17 Million |
-0.009x | +93.77% |
| 2014-12-31 | CN¥782.00 Million ≈ $114.43 Million |
CN¥-108.20 Million ≈ $-15.83 Million |
-0.138x | -340.89% |
| 2013-12-31 | CN¥772.70 Million ≈ $113.07 Million |
CN¥44.38 Million ≈ $6.49 Million |
0.057x | +9.57% |
| 2012-12-31 | CN¥687.93 Million ≈ $100.67 Million |
CN¥36.06 Million ≈ $5.28 Million |
0.052x | -12.56% |
| 2011-12-31 | CN¥648.25 Million ≈ $94.86 Million |
CN¥38.86 Million ≈ $5.69 Million |
0.060x | +23.11% |
| 2010-12-31 | CN¥592.55 Million ≈ $86.71 Million |
CN¥28.86 Million ≈ $4.22 Million |
0.049x | -16.93% |
| 2009-12-31 | CN¥563.53 Million ≈ $82.46 Million |
CN¥33.03 Million ≈ $4.83 Million |
0.059x | -81.36% |
| 2008-12-31 | CN¥78.73 Million ≈ $11.52 Million |
CN¥24.76 Million ≈ $3.62 Million |
0.315x | +591.31% |
| 2007-12-31 | CN¥58.27 Million ≈ $8.53 Million |
CN¥2.65 Million ≈ $387.95K |
0.046x | -86.61% |
| 2006-12-31 | CN¥19.33 Million ≈ $2.83 Million |
CN¥6.57 Million ≈ $961.54K |
0.340x | -- |
About Guangzhou Improve Med Instrument
Improve Medical Instruments Co., Ltd. engages in the provision of relevant technologies, products, and services for clinical laboratory and clinical nursing in China and internationally. It provides clinical laboratory products comprising feces and thrombosis viscoelastic analysis systems; and automatic biosafety decappers; and Q-VELOX, an intelligent molecular diagnostic workstation. The company… Read more